#45 Patient perspectives on cannabinoids for interstitial cystitis/bladder pain syndrome
Patient perspectives on cannabinoids for interstitial cystitis/bladder pain syndrome
Anderson K1, Jenkins D2, Lynch M1, Cox A1
1. Dalhousie University, 2. Queen’s University
KEYWORDS: Painful Bladder Syndrome/Interstitial Cystitis (IC), Quality of Life (QoL), Questionnaire
Interstitial cystitis/bladder pain syndrome (IC/BPS) is a chronic condition often causing a significant impact on quality of life (QoL). The goals of management remain symptom control and maximizing QoL. Cannabinoid receptors have been found in human bladder tissue. Access to cannabis has increased with the rise of legalization in various jurisdictions.
We sought to: 1) Determine if patients with IC/BPS use cannabis products for symptoms of IC/BPS; 2) Elicit perceptions of patients with IC/BPS regarding use of cannabis products; 3) Determine if higher Pain and Urgency/Frequency Symptom Scale (PUF) scores correlate with use of cannabinoid products.